Skip to main content
Premium Trial:

Request an Annual Quote

Luminex's Q2 Revenues Increase 19 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its second-quarter revenues rose 19 percent, with double-digit increases for its systems and consumables sales.

The Austin, Texas-based maker of multiplex systems for research and diagnostics brought in total revenues of $33.2 million for the three months ended June 30, up 19 percent from $27.8 million for Q2 2009. It fell just short of analysts' consensus estimate of $33.6 million in revenues for the quarter.

Its systems sales jumped 20 percent to $7.9 million from $6.1 million, year over year, while consumables were up 45 percent to $9.7 million from $6.7 million. The firm's royalty revenues increased 13 percent to $4.9 million from $4.3 million, but its assay revenues declined 4 percent to $7.4 million from $7.8 million. Luminex reported other revenue of $3.3 million versus $2.9 million for the comparable period of 2009.

The firm noted that system shipments for the second quarter were 219, up 15 percent from the same period a year ago.

Luminex posted net income of $884,000, or $.02 per share, for the quarter, compared to $1.1 million, or $.03 per share, for Q2 2009. Analysts, on average, had expected EPS of $.05.

Its R&D spending increased to $5.9 million from $5 million, and its SG&A spending rose to $15 million from $13.3 million.

Luminex finished the quarter with cash, cash equivalents, and restricted cash of $85 million, as well as $16.5 million in short-term investments.

The firm re-affirmed its FY 2010 revenue guidance of between $138 million and $148 million, which would be between 14 percent and 23 percent growth over 2009.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.